Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

OCTOBER 25, 2018

In fact, both the sectoral and the geographic diversity of superstar firms is greater today than 20 years ago. These “superstar” sectors include financial services such as banking, insurance, and asset management, professional services, internet and software, real estate, and pharmaceuticals and medical products.

Industry 13

Industry Company GDP Bottom-up 13

Strategy Driven

MARCH 18, 2011

Moreover, fixed assets are more difficult to leverage across diverse businesses than capabilities, and they tend to expire, become obsolete, or give way to related services. Companies today operate in a business environment that encourages incoherence. We call this measure the ‘coherence premium.’

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. economy, expands America's global trade, and attracts foreign companies to base operations in the U.S.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

MARCH 16, 2015

Their concerns fell into three broad categories: talent, operating in a global marketplace, and regulation and legislation. Talent Management. ” Other talent management concerns that were mentioned once include: motivating people through hard times, retention and development, and managing diversity and cultural differences. .”

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

JULY 16, 2013

Both paths are problematic — neither is particularly transparent or relies on objective measures and given that many boards are stubborn bastions of white masculinity, pursuing the "right" network can be fraught, especially for women and other diverse candidates. We also looked at results by industry and region.

Telecommunications 8

Telecommunications Biotechnology Health Care Real Estate 8

Harvard Business Review

DECEMBER 5, 2016

It serves vastly diverse populations: toddlers and caregivers, new immigrants, lifelong learners, famous novelists, and scholars. How to provide hyper-local services tailored to the diverse needs of its patrons while also upholding a consistent and high standard of service? in less than five years. in less than five years.

Library 8

Library Strategy Reference Bottom-up 8

Harvard Business Review

JULY 30, 2015

After interviewing several ad agency executives and marketing leaders in a diverse group of businesses — pharmaceutical, high-tech, manufacturing, retail, sports, and others — I’ve found a few common themes that could help explain what is going on. Agencies are slow. . Agencies are stuck on advertising.

Marketing 8

Marketing Advertising Trends Brand 8

Harvard Business Review

OCTOBER 26, 2015

A recent USC study shows that across multiple and diverse markets, industries are 25% more likely to be “highly concentrated” than they were 20 years ago. Where only the largest organizations could operate 24-hour call centers, today, even small organizations have access to companies like Global Response.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Industry Trends 8

Harvard Business Review

JANUARY 31, 2013

On the innovation front, the opportunities are more diverse, but equally powerful. We see advances in materials, processes, and information technology that will make possible entirely new kinds of products and can radically alter how manufacturers operate. Innovations Are Changing The Way We Design Products.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

JUNE 20, 2017

Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency. Prasad, CEO of Dr. Reddy’s, a 33-year-old global pharmaceutical company headquartered in India that produces affordable generic medication.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. To best leverage worldwide creative talent, Reliance MediaWorks operates a global network of creative centers located in Burbank, San Francisco, London, Tokyo, and across India. Cambridge, U.K. facility in Cambridge Science Park.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Strategy Driven

JANUARY 24, 2011

It appears Nokia was not able to coordinate decisions and activities across departments or levels of management. Many innovative ideas became the victims of in-fighting among managers who had competing objectives. When one million bottles of St. For example, some of Toyota’s former U.S. senior executives believe that keeping the U.S.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

OCTOBER 24, 2014

Here are some of the challenges that I’ve observed: Product management. In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations.

Productivity 8

Productivity Products Company Engineering 8

Cooperperson

OCTOBER 21, 2019

IT Manager, Long Island Board of Realtors. By the grace of God and connecting with generous people, Ellen got to the chairman of Merck Sharp & Dohme, one of the largest pharmaceutical companies in the world. ” -Peter Curcio, Chief Operating Officer, Arrow Security. “ -Tommy Panissidi, Manager, Flexible Systems.

Chief Operating Officer 12

Chief Operating Officer Open-book Books Entrepreneur 12

Harvard Business Review

JUNE 24, 2015

Managers and other business leaders face a dilemma: with increasingly diverse environments to manage and rising stakes to get it right, how do they identify the most effective approach to business strategy and marshal the right thinking and behaviors to conceive and execute it, supported by the appropriate frameworks and tools?

Strategy 8

Strategy Competitive Advantage Environment Execution 8

Harvard Business Review

MARCH 6, 2015

Mark, a ten-year veteran of the pharmaceutical R&D world with a Ph.D. in statistics, was the obvious choice to lead the SAS software and data management group of a global healthcare corporation when the current director suddenly departed. You and Your Team. Get better at helping your employees stretch and grow.

Management 8

Management Self-aware Teamwork Pharmaceuticals 8

Harvard Business Review

JULY 20, 2017

This is the challenge for all kinds of disruptors, whether in the auto industry, pharmaceuticals, service industries, or healthcare. We often observe a wide-ranging set of initiatives and investments operating independently, and in some cases, even competitively. Much of corporate venturing today is fragmented and ad hoc.

Innovation 13

Innovation Productivity Products Venture Capitalist 13

Harvard Business Review

AUGUST 23, 2016

Boards of companies operating in the consumer discretionary industry have a disproportionately high representation of Democrats, while boards operating in the industrials and energy and utilities industries skew more Republican. Meanwhile, Democrats place greater importance on technology expertise and risk management.

Politics 8

Politics Committee Telecommunications Diversity 8